Purpose-built for physicians GLP-1 agonists semaglutide, liraglutide may help to treat alcohol use disorder Key takeaways: Participants on semaglutide had reduced risk for hospitalization due to preexisting alcohol use disorder, researchers found
Wegovy is FDA-approved to reduce excess body weight and maintain weight reduction long term in: adults and pediatric patients aged 12 years and older with obesity, and adults with overweight in the presence of at least one weight-related comorbid condition
Medications are well-studied, and the dose is established
Eli Lillys Misleading Marketing Strategy Promoting Trulicity Since Trulicitys launch in 2014, there have been a number of concerns about Eli Lillys marketing strategy
After 30 years, cardiovascular mortality rates for liraglutide 1.2 mg, 1.8 mg, and rosiglitazone reached 69.7%, 68.4%, and 72.5%